TAMs in breast cancer tissues increase tumor cells’ capacity to resist apoptosis via the CCL2/PI3K/Akt/ mammalian target of rapamycin (mTOR) signaling pathway, as found by Li et al.45. The gene discussed is CCL2; the disease is neoplasm.